METiS Pharmaceuticals to Showcase AI-Driven Nucleic Acid Therapeutics at Nucleic Acid Summit 2025 in Shanghai
METiS TechBio
AI-Driven Drug Formulation Developer
Hosted by TansBio, with the Biomedical Industry Association of Shanghai Pudong New Area as the supporting unit,Nucleic Acid Summit 2025: The 4th Annual Conference on Nucleic Acid Drugs and Novel VaccinesWill be held inApril 2-3, 2025, in ShanghaiThe conference will cover the latest developments in nucleic acid drug research and development, explore future trends in vaccine technology, and discuss how to accelerate product development and market entry through innovative delivery technologies, CMC, and quality control processes. In addition, the conference will also explore the R&D of human and veterinary vaccines, as well as strategies for innovative drugs to enter overseas markets.As a global leader in "AI + Drug Delivery," METiS TechBio has always been committed to accelerating innovation in drug delivery systems through AI technology. At this conference,METiS TechBio Co-Founder & CRDO Academician Hongmin ChenandMETiS TechBio Co-Founder & COO Dr. Wang WenshouWill deliver a keynote speech.
Meeting Information
Meeting Name |Nucleic Acid Summit 2025: The 4th China Nucleic Acid Drugs and Novel Vaccines Industry Conference
Speech Time |April 2nd, 11:05-11:30 AM
Speech Topic |AI Technology Empowers mRNA Drug Development
Guest Speaker |METiS TechBio Co-Founder & CRDO Academician Hongmin Chen
2Day Conference
6Major Topic
30+Premium Booth
50+Keynote Speech
1000+Industry Participants
Industry StarAward CeremonyCeremony
High-levelDinner
…
Learn More About METiS TechBio
Related Reading:
DeepSeek Large Inference Model Shocks the World: How Can Chinese Pharmaceutical Companies Leverage the AI Revolution?
METiS TechBio Scientist Discusses miRNA, RNAi, and mRNA Technologies
From AI Dominating the Nobel Prize to Industry Trends: METiS TechBio's Reflections and Forecasts
METiS TechBio 2024 Year-End Review | AI Wave Surges, RNA Opens New Chapter
